Fig. 9From: Identification of potential drug targets for rheumatoid arthritis from genetic insights: a Mendelian randomization studyDocking results of available proteins small molecules. a FEN1 docking Rhein, b FEN1 docking Tyrphostin AG 538, c FEN1 docking Quercetin, d C5 docking Quercetin, e ATP2A1 docked to Quercetin, f IFNGR2 docked to Quercetin, g HLA-DPA1 docking (–)-isoprenalineBack to article page